| scholarly article | Q13442814 |
| P356 | DOI | 10.1681/ASN.2005080891 |
| P698 | PubMed publication ID | 16467444 |
| P50 | author | Sandrine Florquin | Q21264632 |
| Eduard M Scholten | Q125344019 | ||
| Ajda T Rowshani | Q125344054 | ||
| Marian C Roos-van Groningen | Q125344126 | ||
| P2093 | author name string | Frederike J Bemelman | |
| Johan W de Fijter | |||
| Jan A Bruijn | |||
| Hans J Baelde | |||
| Emile de Heer | |||
| Ingeborg M Bajema | |||
| Michael Eikmans | |||
| Patrick M Lelieveld | |||
| P433 | issue | 3 | |
| P304 | page(s) | 881-888 | |
| P577 | publication date | 2006-02-08 | |
| P1433 | published in | Journal of the American Society of Nephrology | Q17123893 |
| P1476 | title | Molecular comparison of calcineurin inhibitor-induced fibrogenic responses in protocol renal transplant biopsies | |
| P478 | volume | 17 |
| Q34753440 | Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients |
| Q36861751 | Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study |
| Q41731968 | Basic and clinical research in the AMC Renal Transplant Unit |
| Q46633572 | Beneficial Immune Effects of Myeloid-Related Proteins in Kidney Transplant Rejection. |
| Q35536149 | CD4-Positive T Cells and M2 Macrophages Dominate the Peritoneal Infiltrate of Patients with Encapsulating Peritoneal Sclerosis. |
| Q38230449 | Calcineurin inhibitor sparing strategies in renal transplantation, part one: Late sparing strategies |
| Q36889001 | Calcineurin inhibitor-free immunosuppression in kidney transplantation |
| Q37064446 | Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity. |
| Q53702610 | Calcineurin inhibitors and nephrotoxicity in children. |
| Q37806767 | Deciphering calcineurin inhibitor nephrotoxicity: a pharmacological approach. |
| Q36796755 | Early epithelial phenotypic changes predict graft fibrosis |
| Q34093890 | Effect of low-dose tacrolimus with mycophenolate mofetil on renal function following liver transplantation |
| Q27027082 | Effector mechanisms of rejection |
| Q30405394 | Evaluation of molecular profiles in calcineurin inhibitor toxicity post-kidney transplant: input to chronic allograft dysfunction |
| Q37229944 | Experience with tacrolimus in children with steroid-resistant nephrotic syndrome |
| Q39035802 | Kidney Fibrosis: Origins and Interventions |
| Q45958491 | Kidney graft function in long-term cyclosporine and tacrolimus treatment: comparative study with nephrotoxicity markers. |
| Q37939057 | Meta-analysis of calcineurin-inhibitor-sparing regimens in kidney transplantation |
| Q37097694 | Minimizing immunosuppression, an alternative approach to reducing side effects: objectives and interim result |
| Q64249132 | Presence of intragraft B cells during acute renal allograft rejection is accompanied by changes in peripheral blood B cell subsets |
| Q46346481 | Prevention of calcineurin inhibitor nephrotoxicity in renal transplantation |
| Q33271012 | Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss. |
| Q37813408 | Rejection and function and chronic allograft dysfunction |
| Q44655473 | Renal ischemia-reperfusion induces a dysbalance of angiopoietins, accompanied by proliferation of pericytes and fibrosis. |
| Q26799916 | Safety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients |
| Q38774503 | Tacrolimus Modulates TGF-β Signaling to Induce Epithelial-Mesenchymal Transition in Human Renal Proximal Tubule Epithelial Cells |
| Q35166453 | Tacrolimus increases Nox4 expression in human renal fibroblasts and induces fibrosis-related genes by aberrant TGF-beta receptor signalling |
| Q92325986 | The Landscape of Digital Pathology in Transplantation: From the Beginning to the Virtual E-Slide |
| Q93010157 | The cannabinoid receptor 1 is involved in renal fibrosis during chronic allograft dysfunction: Proof of concept |
| Q38578386 | The safety of calcineurin inhibitors for kidney-transplant patients |
Search more.